Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06373978 · ClinicalTrials.gov registry record · Phase 4

NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow

A Phase 4 study of Chronic Pain and Elbow Pain, sponsored by The Cleveland Clinic.

Recruiting
Registry status
Phase 4
Development phase
92
Enrollment target
2
Study locations

NCT06373978 is a Phase 4 study of Chronic Pain and Elbow Pain that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 92 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06373978, a Phase 4 study of Chronic Pain and Elbow Pain, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
Phase 4
Development phase
92 participants
Enrollment target
2
Study locations

Study Summary

This study is a double-blind, randomized controlled trial comparing the effectiveness of oral acetaminophen, diclofenac, and tramadol in reducing the consumption of narcotic doses (primary outcome) and minimizing patients' exposure to narcotics (secondary outcome) following an ultrasound-guided percutaneous needle tenotomy procedure on the lateral elbow.

Conditions Studied

Interventions

  • OTHER Acetaminophen
  • DRUG Diclofenac
  • DRUG Tramadol

Study Locations (2)

Florida

  • The Cleveland Clinic Florida - Coral Springs

Ohio

  • The Cleveland Clinic Ohio - Avon

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2024-08-12
Est. Completion 2026-06-30
Phase Phase 4

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT06373978

The ClinicalTrials.gov registry entry for NCT06373978 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Acetaminophen is the first listed.

NCT06373978 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Ohio.

Frequently Asked Questions

What is clinical trial NCT06373978 about?

NCT06373978 is a clinical study titled "NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow". This study is a double-blind, randomized controlled trial comparing the effectiveness of oral acetaminophen, diclofenac, and tramadol in reducing the consumption of narcotic doses (primary outcome) and minimizing patients' exposure to narcotics (secondary outcome) following an ultrasound-guided perc...

What is the current status of trial NCT06373978?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2024-08-12. Estimated completion is 2026-06-30.

What conditions does trial NCT06373978 study?

This clinical trial studies the following conditions: Chronic Pain, Elbow Pain.

What interventions are being tested in trial NCT06373978?

The interventions under investigation include: Acetaminophen (OTHER), Diclofenac (DRUG), Tramadol (DRUG).

Who is sponsoring clinical trial NCT06373978?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06373978 being conducted?

This trial has 2 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.